Pitocin and Postpartum Hemorrhage

• Main Author: Lewis-Roach, Janet
• Language: EN
• Published: Grand Canyon University 2019
• Subjects: Obstetrics|Nursing
• Online Access: http://pqdtopen.proquest.com/#viewpdf?dispub=13807514

<p> Postpartum hemorrhage is the leading cause of maternal mortality and morbidity globally and affects women with a gestational age of 20 weeks and above. To determine whether the utilization of synthetic Pitocin in the intra-partum period has any association to postpartum hemorrhage, the primary investigator encouraged clinicians to continuously utilize the Triton OR to quantify the blood loss for 24 hours after vaginal delivery. The project also entailed chart review of 30 women who labored and delivered at a local hospital in the State of Georgia. One group was given synthetic Pitocin to induce and or augment their labor while the other group did not. Two clinical questions guided the project. What is the difference in the amount of blood loss within 24 hours of vaginal delivery between women who had their labor induced and or augmented with synthetic Pitocin compared to those who spontaneously labored and delivered? Is there any association between the utilization of synthetic Pitocin for the induction and or augmentation of labor, and post-partum hemorrhage within 24 hours of vaginal delivery? Jean Watson theory of human caring guided guide the project. A quantitative comparative design was utilized for the project. The mean blood loss for those women who received synthetic Pitocin was 279.20 milliliters, while that of women who did not receive synthetic Pitocin was 293.67 milliliters; hence there was no association between the utilization of synthetic Pitocin in the intra-partum period and postpartum hemorrhage (<i>p</i> >.05). Conducting the project on a larger scale is paramount in determining whether there is any association between synthetic Pitocin utilization in the intra-partum period and postpartum hemorrhage.</p><p>